Related Experiment Video
Updated: Aug 29, 2025

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
Published on: March 1, 2019
CLN7/MFSD8 may be an important factor for SARS-CoV-2 cell entry
Elena-Sofia Heinl1, Sebastian Lorenz1, Barbara Schmidt2
1Medical Cell Biology, University Regensburg, 93053 Regensburg, Germany.
Abstract:
The SARS-CoV-2 virus has triggered a worldwide pandemic. According to the BioGrid database, CLN7 (MFSD8) is thought to interact with several viral proteins. The aim of this work was to investigate a possible involvement of CLN7 in the infection process. Experiments on a CLN7-deficient HEK293T cell line exhibited a 90% reduced viral load compared to wild-type cells. This observation may be linked to the finding that CLN7 ko cells have a significantly reduced GM1 content in their cell membrane. GM1 is found highly enriched in lipid rafts, which are thought to play an important role in SARS-CoV-2 infection. In contrast, overexpression of CLN7 led to an increase in viral load. This study provides evidence that CLN7 is involved in SARS-CoV-2 infection. This makes it a potential pharmacological target for drug development against COVID-19. Furthermore, it provides insights into the physiological function of CLN7 where still only little is known about.
Insights
This study reveals CLN7 protein is crucial for SARS-CoV-2 infection. Reducing CLN7 significantly lowers viral load, identifying it as a potential drug target for COVID-19 treatment.
Area of Science:
- Virology
- Cell Biology
- Molecular Medicine
Background:
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) causes a global pandemic.
- CLN7 (MFSD8) is a protein suggested to interact with SARS-CoV-2 proteins.
- The role of CLN7 in viral infection remains largely unknown.
Purpose of the Study:
- To investigate the involvement of CLN7 in the SARS-CoV-2 infection process.
- To explore CLN7 as a potential therapeutic target for COVID-19.
Main Methods:
- Utilized CLN7-deficient HEK293T cell lines and wild-type controls.
- Quantified viral load in cells with altered CLN7 expression.
- Assessed GM1 ganglioside content in cell membranes.
Main Results:
- CLN7-deficient cells showed a 90% reduction in SARS-CoV-2 viral load compared to wild-type.
- CLN7 knockout cells exhibited significantly reduced GM1 ganglioside levels in their cell membrane.
- Overexpression of CLN7 resulted in an increased viral load.
Conclusions:
- CLN7 plays a significant role in facilitating SARS-CoV-2 infection.
- Reduced GM1 ganglioside content in CLN7-deficient cells may impair viral entry.
- CLN7 represents a promising pharmacological target for developing novel COVID-19 therapeutics.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Single Nucleotide Polymorphisms-SNPs
Leaky Scanning
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...

